Cargando…
Integrating single-cell RNA-seq and bulk RNA-seq to construct prognostic signatures to explore the role of glutamine metabolism in breast cancer
BACKGROUND: Although breast cancer (BC) treatment has entered the era of precision therapy, the prognosis is good in the case of comprehensive multimodal treatment such as neoadjuvant, endocrine, and targeted therapy. However, due to its high heterogeneity, some patients still cannot benefit from co...
Autores principales: | Pei, Shengbin, Zhang, Pengpeng, Chen, Huilin, Zhao, Shuhan, Dai, Yuhan, Yang, Lili, Kang, Yakun, Zheng, Mingjie, Xia, Yiqin, Xie, Hui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9950399/ https://www.ncbi.nlm.nih.gov/pubmed/36843602 http://dx.doi.org/10.3389/fendo.2023.1135297 |
Ejemplares similares
-
Exploring PANoptosis in breast cancer based on scRNA-seq and bulk-seq
por: He, Puxing, et al.
Publicado: (2023) -
Mast cell marker gene signature: prognosis and immunotherapy response prediction in lung adenocarcinoma through integrated scRNA-seq and bulk RNA-seq
por: Zhang, Pengpeng, et al.
Publicado: (2023) -
Exploring the role of sphingolipid-related genes in clinical outcomes of breast cancer
por: Pei, Shengbin, et al.
Publicado: (2023) -
By integrating single-cell RNA-seq and bulk RNA-seq in sphingolipid metabolism, CACYBP was identified as a potential therapeutic target in lung adenocarcinoma
por: Zhang, Pengpeng, et al.
Publicado: (2023) -
Integrating multiple machine learning methods to construct glutamine metabolism-related signatures in lung adenocarcinoma
por: Zhang, Pengpeng, et al.
Publicado: (2023)